- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/4965 - Non-condensed pyrazines
Patent holdings for IPC class A61K 31/4965
Total number of patents in this class: 1802
10-year publication summary
|
95
|
114
|
129
|
126
|
163
|
140
|
128
|
86
|
105
|
56
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Novartis AG | 10178 |
45 |
| Nippon Shinyaku Co., Ltd. | 326 |
45 |
| Actelion Pharmaceuticals Ltd | 492 |
34 |
| Parion Sciences, Inc. | 54 |
31 |
| Vertex Pharmaceuticals Incorporated | 1579 |
26 |
| FUJIFILM Toyama Chemical Co., Ltd. | 114 |
25 |
| Guangzhou Magpie Pharmaceuticals Co., Ltd. | 34 |
22 |
| F. Hoffmann-La Roche AG | 7815 |
18 |
| Janssen Pharmaceutica N.V. | 3161 |
18 |
| Medibeacon, Inc. | 139 |
18 |
| Bristol-myers Squibb Company | 4748 |
17 |
| Boehringer Ingelheim International GmbH | 4483 |
17 |
| AstraZeneca AB | 2824 |
16 |
| Morehouse School of Medicine | 164 |
16 |
| Abbvie Inc. | 1822 |
15 |
| Toyama Chemical Co., Ltd. | 88 |
15 |
| Merck Sharp & Dohme LLC | 3736 |
15 |
| The Regents of the University of California | 20802 |
14 |
| Dana-Farber Cancer Institute, Inc. | 2668 |
13 |
| Merck Sharp & Dohme Corp. | 2183 |
12 |
| Other owners | 1370 |